Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06338176
Status:
RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-03-23
Brief Title:
Optimizing the Management of Staphylococcus Aureus Bacteremia OPTIMUS-SAB
Sponsor:
University of Alberta
Organization:
University of Alberta
Study Overview
Official Title:
Optimizing the Management of Staphylococcus Aureus Bacteremia OPTIMUS-SAB A Stepped Wedge Clinical Trial Evaluating the Effectiveness of a Centralized S Aureus Management Model
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Staphylococcus aureus bacteremia SAB is associated with high morbidity and mortality rates with an incidence disproportionately higher in vulnerable populations Management according to evidence-based care parameters in particular Infectious Diseases ID consultation is associated with improved mortality SAB management is suboptimal in Alberta compared to other jurisdictions An Alberta-based pilot study confirmed that timely recommendations to optimize SAB care including ID consultation was associated with improved adherence to all evidence-based quality-of-care indicators
Leveraging this pilot work the investigators aim to implement OPTIMUS-SAB an enhanced model of the pilot to optimize and standardize SAB management across Alberta The implementation study will be a zone-based acute care site stepped wedge design OPTIMUS-SAB will consist of a centralized SAB care team whom will receive automated notification of all blood cultures positive for S aureus allowing them to review the patients medical chart and make preliminary management recommendations according to an evidence-based care bundle
The investigators will evaluate adherence to evidence-based SAB quality-of-care indicators before and after OPTIMUS-SAB implementation and expect this to improve with a resultant reduction in duration of bacteremia length of stay readmission rates and mortality In turn this will translate into cost savings for the health care system
Leveraging this pilot work the investigators aim to implement OPTIMUS-SAB an enhanced model of the pilot to optimize and standardize SAB management across Alberta The implementation study will be a zone-based acute care site stepped wedge design OPTIMUS-SAB will consist of a centralized SAB care team whom will receive automated notification of all blood cultures positive for S aureus allowing them to review the patients medical chart and make preliminary management recommendations according to an evidence-based care bundle
The investigators will evaluate adherence to evidence-based SAB quality-of-care indicators before and after OPTIMUS-SAB implementation and expect this to improve with a resultant reduction in duration of bacteremia length of stay readmission rates and mortality In turn this will translate into cost savings for the health care system
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None